|
May 19
|
CASI Pharmaceuticals Provides Business and Clinical Update
|
|
May 12
|
CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China
|
|
May 7
|
CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement
|